𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Detectable tumor cells in the blood and bone marrow : Smoke or fire?

✍ Scribed by Susan F. Slovin; Howard I. Scher


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
55 KB
Volume
83
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Flow cytometric analysis of peripheral b
✍ Yoshihiro Komada; Xao-Li Zhang; Yan-Wen Zhou; Hiroto Inaba; Takao Deguchi; Eiich πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 211 KB πŸ‘ 2 views

## Background: Several sensitive surveillance tests reportedly have been used to detect occult neuroblastoma (nb) cells in peripheral blood (pb) and bone marrow (bm). they may be useful in monitoring minimal residual tumor cells. the authors report the feasibility and clinical usefulness of a sensi

Quantitative analysis of disseminated tu
✍ GΓ‘bor MΓ©hes; Thomas LΓΆrch; Peter F. Ambros πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 141 KB πŸ‘ 1 views

Accurate quantification of disseminated tumor cells in hematological samples is of fundamental importance in clinical oncology. However, even highly standardized protocols allow only a rough estimation of the total analyzed cell number, as sample processing may have adverse effects on the number of

Sequential detection of tumor cells in t
✍ Yuji Miyajima; Keizo Horibe; Minoru Fukuda; Kimikazu Matsumoto; Shin-ichiro Numa πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 485 KB πŸ‘ 2 views

The aim of this study was to evaluate the changes of tumor cell contamination in bone marrow (BM) and peripheral blood (PB) during the clinical course of patients with advanced neuroblastoma by detecting tyrosine hydroxylase (TII) mRNA to clarify the appropriate source and time for harvesting hemato

Detection of circulating tumor cells in
✍ Michael C. Mitas; Uzair B. Chaudhary; David T. Marshall; Sebastiano Gattoni-Cell πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 121 KB πŸ‘ 2 views

## Detection of circulating tumor cells in the peripheral blood of patients with androgen-independent, advanced or metastatic prostate cancer To the Editor: The presence of circulating tumor cells (CTC) in the peripheral blood of cancer patients has attracted a great deal of attention among invest